Publication

B-cell isotype control in atopy and asthma assessed with cDNA array technology

Journal Paper/Review - Apr 1, 2001

Units
PubMed

Citation
Brutsche M, Wood P, Mogulkoc N, Custovic A, Egan J, Woodcock A. B-cell isotype control in atopy and asthma assessed with cDNA array technology. American journal of physiology. Lung cellular and molecular physiology 2001; 280:L627-37.
Type
Journal Paper/Review (English)
Journal
American journal of physiology. Lung cellular and molecular physiology 2001; 280
Publication Date
Apr 1, 2001
Issn Print
1040-0605
Pages
L627-37
Brief description/objective

B-cell isotype switching and the production of IgE is regulated by a variety of gene products through different mechanisms. A better understanding of these processes has the potential to identify markers of disease and new therapeutic targets. The aim of the study was to investigate human B-cell isotype control and IgE production in atopy and asthma with cDNA array technology. Eighteen atopic asthmatic, eight atopic nonasthmatic, and fourteen healthy control subjects were included. Peripheral blood mononuclear cells were separated by gradient centrifugation, mRNA was purified, and the reverse-transcribed probes were hybridized to cDNA membranes. Group differences were assessed with the Mann-Whitney U-test. Twenty-three of seventy-eight tested IgE-related genes had significantly altered expression in atopy and asthma compared with that in the healthy subjects. The differentially expressed genes include surface molecules involved in T- and B-cell interaction and activation, cytokines, intracellular signaling products, and transcription factors. In conclusion, both atopic nonasthmatic and atopic asthmatic individuals had activated proinflammatory pathways, a minimal requirement for B-cell isotype switching, and a clear net pro-IgE cytokine climate.